Palatin Technologies (PTN)

• Market cap: $22.4M
• 1 day: -7.57%
• 5 days: -10.4%
• 1 month: -12.7%
• 3 months: -44.14%
• 6 months: -55.07%
• Year to date: -21.62%
• 1 year: 13.95%
• 5 years: -98.19%
• 10 years: -97.97%
• Sector: Healthcare
• Industry: Biotechnology

About: Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical needs and commercial potential. The Company's business is in one operating segment: life science.

Employees: 29